| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.34B | $3.42B | $3.09B |
| YoY Revenue Growth % | -2.3% | +10.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $499.8M | $551.3M | $342.8M |
| Operating Margin % | 14.9% | 16.1% | 11.1% |
| Net Income (GAAP) | $444.8M | $476.4M | $297.1M |
| EBITDA (Normalized) | $620.2M | $674.5M | $454.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $547.1M | $767.8M | $510.5M |
| Capital Expenditures (CapEx) | $150.5M | $154.0M | $139.3M |
| Free Cash Flow (FCF) | $396.6M | $613.8M | $371.2M |
| FCF Margin % | 11.9% | 17.9% | 12.0% |
| Return on Invested Capital (ROIC %) | 13.5% | 15.9% | 12.0% |
| Cash & Short-Term Equivalents | $141.9M | $266.8M | — |
| Total Debt (Short + Long Term) | $312.1M | $350.8M | $873.6M |
| Total Stockholders' Equity | $2.76B | $2.65B | $1.79B |